美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=MOUNJARO"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
MOUNJARO (AUTOINJECTOR) 215866 001 NDA TIRZEPATIDE SOLUTION;SUBCUTANEOUS 2.5MG/0.5ML (2.5MG/0.5ML) Yes Yes 2022/05/13 2022/05/13 ELI LILLY AND CO Prescription
MOUNJARO (AUTOINJECTOR) 215866 002 NDA TIRZEPATIDE SOLUTION;SUBCUTANEOUS 5MG/0.5ML (5MG/0.5ML) Yes Yes 2022/05/13 2022/05/13 ELI LILLY AND CO Prescription
MOUNJARO (AUTOINJECTOR) 215866 003 NDA TIRZEPATIDE SOLUTION;SUBCUTANEOUS 7.5MG/0.5ML (7.5MG/0.5ML) Yes Yes 2022/05/13 2022/05/13 ELI LILLY AND CO Prescription
MOUNJARO (AUTOINJECTOR) 215866 004 NDA TIRZEPATIDE SOLUTION;SUBCUTANEOUS 10MG/0.5ML (10MG/0.5ML) Yes Yes 2022/05/13 2022/05/13 ELI LILLY AND CO Prescription
MOUNJARO (AUTOINJECTOR) 215866 005 NDA TIRZEPATIDE SOLUTION;SUBCUTANEOUS 12.5MG/0.5ML (12.5MG/0.5ML) Yes Yes 2022/05/13 2022/05/13 ELI LILLY AND CO Prescription
MOUNJARO (AUTOINJECTOR) 215866 006 NDA TIRZEPATIDE SOLUTION;SUBCUTANEOUS 15MG/0.5ML (15MG/0.5ML) Yes Yes 2022/05/13 2022/05/13 ELI LILLY AND CO Prescription
MOUNJARO 215866 007 NDA TIRZEPATIDE SOLUTION;SUBCUTANEOUS 2.5MG/0.5ML (2.5MG/0.5ML) Yes Yes 2022/05/13 2023/07/28 ELI LILLY AND CO Prescription
MOUNJARO 215866 008 NDA TIRZEPATIDE SOLUTION;SUBCUTANEOUS 5MG/0.5ML (5MG/0.5ML) Yes Yes 2022/05/13 2023/07/28 ELI LILLY AND CO Prescription
MOUNJARO 215866 009 NDA TIRZEPATIDE SOLUTION;SUBCUTANEOUS 7.5MG/0.5ML (7.5MG/0.5ML) Yes Yes 2022/05/13 2023/07/28 ELI LILLY AND CO Prescription
MOUNJARO 215866 010 NDA TIRZEPATIDE SOLUTION;SUBCUTANEOUS 10MG/0.5ML (10MG/0.5ML) Yes Yes 2022/05/13 2023/07/28 ELI LILLY AND CO Prescription
MOUNJARO 215866 011 NDA TIRZEPATIDE SOLUTION;SUBCUTANEOUS 12.5MG/0.5ML (12.5MG/0.5ML) Yes Yes 2022/05/13 2023/07/28 ELI LILLY AND CO Prescription
MOUNJARO 215866 012 NDA TIRZEPATIDE SOLUTION;SUBCUTANEOUS 15MG/0.5ML (15MG/0.5ML) Yes Yes 2022/05/13 2023/07/28 ELI LILLY AND CO Prescription
药品名称,活性成分,申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database